The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Open accessAbstract
Decreased fibrinolytic capacity has been suggested to accelerate the process of arterial atherogenesis by facilitating thrombosis and fibrin deposition within developing atherosclerotic lesions. Type 1 plasminogen activator inhibitor (PAI-1) is the primary inhibitor of tissue-type plasminogen activator and has been found to be increased in a number of clinical conditions generally defined as prothrombotic. To investigate the potential role of this inhibitor in atherosclerosis, we examined the expression of PAI-1 mRNA in segments of 11 severely diseased and 5 relatively normal human arteries obtained from 16 different patients undergoing reconstructive surgery for aortic occlusive or aneurysmal disease. Densitometric scanning of RNA (Northern) blot autoradiograms revealed significantly increased levels of PAI-1 mRNA in severely atherosclerotic vessels (mean densitometric value, 1.7 +/- 0.28 SEM) compared with normal or mildly affected arteries (mean densitometric value, 0.63 +/- 0.09 SEM; P less than 0.05). In most instances, the level of PAI-1 mRNA was correlated with the degree of atherosclerosis. Analysis of adjacent tissue sections from the same patients by in situ hybridization demonstrated an abundance of PAI-1 mRNA-positive cells within the thickened intima of atherosclerotic arteries, mainly around the base of the plaque. PAI-1 mRNA could also be detected in cells scattered within the necrotic material and in endothelial cells of adventitial vessels. In contrast to these results, PAI-1 mRNA was visualized primarily within luminal endothelial cells of normal-appearing aortic tissue. Our data provide initial evidence for the increased expression of PAI-1 mRNA in severely atherosclerotic human arteries and suggest a role for PAI-1 in the progression of human atherosclerotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
Schleef, R. R., Bevilacqua, M. P., Sawdey, M., Gimbrone, M. A., & Loskutoff, D. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60636-2 · Cited by 546
Self-citationAssoian, R. K., & Sporn, M. B. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.4.1217 · Cited by 538
Wilcox, J. N., Smith, K. M., Williams, L. T., Schwartz, S. M., & Gordon, D. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113671 · Cited by 479
Suffredini, A. F., Harpel, P. C., & Parrillo, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201802 · Cited by 476
Detection and localization of tumor necrosis factor in human atheroma
Barath, P., Fishbein, M. C., Cao, J., Berenson, J., Helfant, R. H., & Forrester, J. S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90291-8 · Cited by 449
Vague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M. C., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Sawdey, M. S., & Loskutoff, D. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115440 · Cited by 410
Self-citationColucci, M., Paramo, J. A., & Collen, D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111777 · Cited by 390
Ny, T., Sawdey, M., Lawrence, D., Millan, J. L., & Loskutoff, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6776 · Cited by 379
Self-citationSaksela, O., Moscatelli, D., & Rifkin, D. B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.957 · Cited by 367
Juhan-Vague, I., Valadier, J., Alessi, M. C., Aillaud, M. F., Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A., & Collen, D. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651064 · Cited by 362
Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
Paramo, J. A., Colucci, M., Collen, D., & van de Werf, F. (1985) · BMJ · doi:10.1136/bmj.291.6495.573 · Cited by 302
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
Auwerx, J., Bouillon, R., Collen, D., & Geboers, J. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.68 · Cited by 276
Sawdey, M., Podor, T. J., & Loskutoff, D. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81633-7 · Cited by 242
Self-citationMosse, P. R. L., CAMPBELL, G. R., Wang, Z. L., & Campbell, J. H. (1985) · PubMed · Cited by 226
OOLOFESSON, B. O., DAHLÈN, G., & NILSSON, T. K. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059384 · Cited by 224
Juhan-Vague, I., Vague, P., Alessi, M., Badier, C., Valadier, J., Aillaud, M.-F., & Atlan, C. (1987) · PubMed · Cited by 218
Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef, R. R., Higgins, D. L., Pillemer, E., & Levitt, L. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114076 · Cited by 210
Aznar, J., Estelles, A., Tormo, G., Sapena, P., Tormo, V, Blanch, S., & Espana, F. (1988) · Heart · doi:10.1136/hrt.59.5.535 · Cited by 188
Mimuro, J., Schleef, R., & Loskutoff, D. (1987) · Blood · doi:10.1182/blood.v70.3.721.721 · Cited by 185
Self-citationPyke, C., Kristensen, P. K., Ralfkiaer, E. M., Eriksen, J., & Danø, K. (1991) · PubMed · Cited by 143
Hartzell, S. W., Ryder, K., Lanahan, A. A., Lau, L. F., & Nathan, D. F. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2567 · Cited by 133
Reilly, C., & McFall, R. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92836-x · Cited by 128
Oseroff, A., Krishnamurti, C., Hassett, A., Tang, D. B., & Alving, B. M. (1989) · PubMed · Cited by 73
Cited by
The Intima: Soil for Atherosclerosis and Restenosis
Schwartz, S. M., deBlois, D., & O’Brien, E. R. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.445 · Cited by 971
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 806
Eriksson, P., Kallin, B., van 't Hooft, F. M., Båvenholm, P., & Hamsten, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1851 · Cited by 739
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Metadata
- Authors
- Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., & Loskutoff, D. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-08
- Volume
- 89
- Issue
- 15
- Pages
- 6998-7002
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2070627144
- Cited by
- 543
- References
- 31
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.